Noticias

Noticias

  • Título: Live case demonstration using Aorfix at LINC 2014
  • Fecha: 30-01-2014
  • London, UK and Irvine, CA, 30 January, 2014 – Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company focused on Endovascular Aortic Repair (“EVAR”) of abdominal aortic aneurysms (“AAAs”), announces that yesterday a team of surgeons, led by Dr. Andrej Schmidt, Oberarzt (Senior Physician) Angiologie, Leipzig Park-Krankenhaus, successfully performed a live case demonstration of a challenging AAA repair using Aorfix™, the Company's flexible endovascular stent graft, to over 500 physicians at the 2014 Leipzig Interventional Course (LINC), Leipziger Messe, Leipzig, Germany.

    Prior to the live case Dr Schmidt demonstrated the Company’s new simulation technology, developed in conjunction with Simbionix USA Corporation, which uses a patient CT scan to allow physicians to practice the procedure on a simulation of that patient’s particular AAA anatomy ahead of the actual surgery.

    During the procedure, which was broadcast live from Park Hospital Leipzig, a panel of prominent vascular surgeons, interventional radiologists and interventional cardiologists, chaired by Professor Vicente Riambau, Professor and Chief of Vascular Surgery, Hospital Clinic of Barcelona, gave a series of presentations discussing their experiences of Aorfix in complex AAA anatomy.

    Aorfix is the only AAA stent graft approved in Europe and the US, for the treatment of patients with neck angulations up to and including 90 degrees.

    Simon Hubbert, CEO of Lombard Medical Technologies, commented:
    “LINC is a very high profile event for international physicians and provides the ideal platform to demonstrate the advantages of Aorfix in the treatment of challenging AAA anatomy. We are also delighted to have the opportunity to showcase our new simulation technology, which we believe will significantly enhance the training experience for physicians using Aorfix.

    Professor Vicente Riambau commented:
    “Aorfix provides physicians with a minimally invasive treatment option for patients with tortuous AAA anatomies who would otherwise require open surgery, which is more invasive and typically carries higher associated risks.”


  • Fuente: endovascular.es